Clinical Trial Update: Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of Kyowa Kirin's monoclonal antibody KHK4083 for moderate ulcerative colitis completed; results posted March 5, 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• KHK4083

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Ulcerative Colitis, Digestive System Diseases | Phase 2 | Status: COMPLETED | Results posted: 2020-03-05